Categories: Clinical TrialNews

Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

19,000-square-foot facility reflects the company’s recent growth and continued commitment to the region

MORRISVILLE, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) — Science 37, a leader in enhancing patient access to clinical trials, today announced the grand opening of its new, 19,000-square-foot corporate headquarters in Morrisville, North Carolina, in the heart of Research Triangle Park.

The new, state-of-the-art facility, will serve as a hub for all Science 37 operations, enabling cross-functional teams with greater opportunities for collaborative problem-solving and integrated solution delivery. Centralizing operations in one facility will enable Science 37 to deliver patient recruitment and study conduct support on behalf of clinical trial sponsors with greater consistency, speed, and quality.

When asked about relocating to their new offices, Science 37 Chief Executive Officer, David Coman, stated, “Practically speaking, we’re better situated than ever to help our sponsors navigate the challenges of recruiting, enrolling, and treating difficult-to-reach patient populations. Symbolically, this move is just as important. It demonstrates our commitment to the region and to helping our sponsors improve their probability of success.”

To learn more about the Science 37, please visit www.science37.com.

About Science 37

Science 37’s mission is to accelerate clinical research by enabling universal trial access for patients. Through our solutions; the Metasite™ and Patient Recruitment, we accelerate enrollment by expanding the reach of clinical trials to patients beyond the traditional site and rigorously qualifying patients prior to referring them to a traditional site. Our solutions are powered by a proprietary technology stack with in-house medical and operational experts that enhance quality through standardized workflows and best-in-class study orchestration. To learn more, visit www.science37.com, or email science37@science37.com.

To view studies that Science 37 is actively recruiting for, please visit https://studies.science37.com/current-studies.

Media Inquiries

Science 37
PR@science37.com

Staff

Recent Posts

NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia

Publication of Independent Study Heightens Demand for UroShield ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the…

42 minutes ago

Adagio Medical Appoints Deborah Kaster as Chief Business Officer

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical (Nasdaq: ADGM), a leading innovator in catheter ablation technologies for…

43 minutes ago

Adagio Medical Appoints Deborah Kaster as Chief Business Officer

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical (Nasdaq: ADGM), a leading innovator in catheter ablation technologies for…

43 minutes ago

CORRECTING and REPLACING ExThera Medical Receives MTEC Award for Pivotal Sepsis Trial

Randomized trial at LSU Health Shreveport will evaluate Seraph 100 Blood Filter's effectiveness in treating…

44 minutes ago

Stride Autism Centers Named a Winner of the 2025 Top Workplaces USA Today During Autism Acceptance Month

Stride Expands Across the Midwest, Celebrating its Tenth Center in Iowa and Sixth in Nebraska…

48 minutes ago

Connect Biopharma Announces Positive Type C Meeting with the FDA for Rademikibart

– FDA aligned on plan to initiate parallel Phase 2 trials of rademikibart in patients…

48 minutes ago